Guidance Document for Industry - Review of Drug Brand Names
Guidance Document for Industry - Review of Drug Brand Names is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-07-07. On CanQuery you can follow the original downloads. Files are available in English and French.
To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-07
Data overview
- Formats
- HTML
- File languages
- English, French